Click here to access the most recent myeloma news, abstracts, and clinical trials information. Highlights From the 38th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida Senator Hutchison, Geraldine Ferraro, and Blood Cancer Coalition play key role in House passage of Hematological Cancer Act MMRF Launches Cutting-Edge Clinical Trials Monitor (CTM) FDA ...

Study to estimate the level of fatigue and frequency of fatigue cases among Hodgkin's disease survivors (HDS) and compare them with normative data from the general population.

Recent studies have suggested that lymphocyte-predominant Hodgkin's disease (LPHD) is both clinically and pathologically distinct from other forms of Hodgkin's disease, including classical Hodgkin's disease (CHD). However, large-scale clinical studies were lacking. This multicenter, retrospective study investigated the clinical characteristics and course of LPHD patients and lymphocyte-rich classical Hodgkin's disease (LRCHD) patients classified according to morphologic and immunophenotypic criteria.

omputed tomography (CT) scans of the neck and chest are obtained at diagnosis of Hodgkin's disease to establish disease extent, plan radiotherapy, and serve as baseline studies for subsequent evaluation of response to therapy. However, differences in interpretation may occur even among experienced radiologists. This study was designed to test the extent of variation among expert radiologists' interpretations and to assess how their interpretations differed from that of the primary (institutional) radiologis